WeedOut is a technology company.
WeedOut has raised $8.0M across 1 funding round.
WeedOut has raised $8.0M in total across 1 funding round.
WeedOut has raised $8.0M in total across 1 funding round.
WeedOut's investors include Fulcrum Global Capital, Innova Memphis, Leaps by Bayer.
WeedOUT is an Israeli ag-tech startup developing novel bio-herbicide solutions to combat herbicide-resistant weeds, a major threat to global agriculture and food security.[1][2][3] The company produces proprietary sterile pollen derived from male weeds, applied during the flowering period to fertilize female weeds and produce nonviable seeds, preventing reproduction and reducing weed populations without additional chemicals.[3][4] Targeting crops like corn, soybeans, cotton, and sugar beets affected by weeds such as Palmer amaranth—which can slash corn yields by 90% and soybean yields by 80%—WeedOUT serves farmers in regions including the US (Georgia, Nebraska), Brazil, and Argentina.[1][3] In 2024, it raised $8.1 million in Series A funding led by Fulcrum Global Capital, with participation from Bunge Ventures and Clay Capital, plus grants from the Israeli Innovation Authority, to expand field trials and seek EPA approval for its first product.[1][6] Recognized as the best Israeli ag-tech company at AgriVest 2018 and a Horizon 2020 Phase 1 winner, WeedOUT drives sustainable farming by cutting chemical use, boosting yields, and curbing resistance evolution.[2]
WeedOUT was co-founded by Efrat Lidor Nili, PhD, who serves as co-CEO, drawing on expertise to address aggressive weeds competing with crops for resources like soil, water, nutrients, and sunlight.[1] The idea emerged from observing evolutionary drift: chemical herbicides kill susceptible weeds, but resistant "escapers" mature, reproduce, and dominate populations.[4] Inspired by 1940s sterile insect techniques for mosquitoes and flies, WeedOUT pioneered applying sterile pollen to weeds—using proprietary pollen from male Palmer amaranth plants to outcompete natural pollination and yield nonviable seeds.[3][4] Early traction included successful field trials in Israel and the US demonstrating high efficacy against Palmer amaranth, awards like AgriVest 2018, and Horizon 2020 funding, paving the way for the 2024 Series A raise and EPA submission.[1][2][4]
WeedOUT rides the sustainable ag-tech wave, tackling herbicide resistance exacerbated by prolonged glyphosate use, which has created "superweeds" threatening food security amid climate pressures and population growth.[1][3] Timing aligns with global shifts toward biologicals and integrated weed management, as chemical efficacy wanes—Palmer amaranth alone devastates US, Brazilian, and Argentine row crops.[1] Market forces like regulatory scrutiny on chemicals, demand for reduced inputs, and VC interest in climate-resilient farming (e.g., Fulcrum's farmer ties) favor its approach.[1][3] By enabling more food production sustainably, WeedOUT influences the ecosystem, supporting precision ag trends and potentially disrupting a $30B+ herbicide market with bio-alternatives.[3]
WeedOUT is poised for commercialization with EPA approval imminent, expanding trials, and new formulations for additional weeds, potentially capturing early-mover advantage in bio-herbicides.[1] Rising resistance, regulatory pushes for greens, and ag-tech funding momentum will shape its path, with partnerships like Bunge accelerating adoption.[1][6] Its influence may evolve from niche innovator to ecosystem shaper, humanizing the fight against "invisible" threats like weeds that silently erode yields—proving biology can outsmart evolution in sustainable agriculture.[3][4]
WeedOut has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Series A in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $8.0M Series A | Fulcrum Global Capital, Innova Memphis, Leaps by Bayer |